Log in to your Inderes Free account to see all free content on this page.
Orion
66.00 EUR
-1.27 %
14,380 following
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarterly estimates
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Orion
| Q2/25 | Q3/25 | Q4/25 | 2025 | Q1/26 | Q2/26e | Q3/26e | Q4/26e | 2026e | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 416.5 | 422.8 | 695.3 | 1,889.5 | 417.7 | 505.0 | 522.7 | 626.0 | 2,071.4 |
| EBITDA | 118.6 | 135.2 | 344.2 | 689.5 | 130.4 | 168.1 | 193.7 | 274.8 | 766.9 |
| EBIT (adj.) | 104.6 | 121.0 | 328.1 | 631.6 | 114.8 | 152.5 | 178.1 | 259.2 | 704.5 |
| EBIT | 104.6 | 121.0 | 328.1 | 631.6 | 114.8 | 152.5 | 178.1 | 259.2 | 704.5 |
| EBIT-% (adj.) | 25.1 % | 28.6 % | 47.2 % | 33.4 % | 27.5 % | 30.2 % | 34.1 % | 41.4 % | 34.0 % |
| EBIT-% | 25.1 % | 28.6 % | 47.2 % | 33.4 % | 27.5 % | 30.2 % | 34.1 % | 41.4 % | 34.0 % |
| Profit before taxes | 103.4 | 120.4 | 327.0 | 627.7 | 113.4 | 151.5 | 177.1 | 258.2 | 700.1 |
| Net income | 82.5 | 96.0 | 260.4 | 500.2 | 90.4 | 119.4 | 139.7 | 203.7 | 553.3 |
Login required
This content is only available for logged in users